Analysis of adherence to postpartum screening for early dysglycemia in women with previous gestational diabetes

Sara Cvijanović; Nebojša Lalić; Milica Stoiljković

doi:10.5937/mp76-54639

Sara Cvijanović Faculty of Medicine University of Belgrade
Nebojša Lalić Faculty of Medicine University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia
Milica Stoiljković Faculty of Medicine University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia https://orcid.org/0009-0000-1322-0107

DOI: https://doi.org/10.5937/mp76-54639

Keywords: screening adherence, gestational diabetes, early postpartum dysglycemia

Abstract

Introduction: Previous studies have shown that women with gestational diabetes (GD) are at higher risk for residual postpartum dysglycemia. Nevertheless, adherence to early postpartum screening among women with previous GD is extremely unsatisfactory.

Aim: Analysis of clinical, anthropometric and sociodemographic characteristics of women with previous GD who were screened during the early postpartum period for residual dysglycemia.

Material and Methods: 102 pregnant women with GD were divided into groups based on the early postpartum screening for dysglycemia: group A, screened (n=19), and group B, not screened (n=83). We analysed age, body mass index (BMI), parity, smoking habits, having GD in previous and gestational hypertension in the current pregnancy, family history of type 2 diabetes (T2D), glycemic parameters (fasting glucose (FG) and HbA1c in the 2nd and 3rd trimester), therapeutic regimen, number of endocrinology outpatient visits and hospitalizations, pregnancy outcomes and results of screening oral glucose tolerance test using appropriate statistics.

Results: Postpartum screening was conducted in 18.6% (group A), among whom prediabetes was diagnosed in 26.3% of women with previous GD. Women in group A were older (36.21±5.05) than in group B (33.48±5.57years, p=0.047). Groups did not differ regarding preconception BMI (A: 28.03±5.69 kg/m² vs B: 28.17±6.84 kg/m², p=0.971), in second and third trimester FG*- (A: 4.64±0.92 mmol/L vs B: 4.62±0.77 mmol/L, p=0.953; A: 4.61±0.73 mmol/L vs B: 4.91±1.02 mmol/L, p=0.507, respectively) and HbA1c (A: 5.06±0.40% vs B: 5.18±0.64%, p=0.621; A: 5.30±0.34% vs B: 5.25±0.54%, p=0.690, respectively). On the other hand, women in group A (3.57±1.51) more frequently attended outpatient endocrinology examinations than women in group B (2.68±1.16, p=0.028).

Conclusion: Our results implied very low adherence to early postpartum screening, while women with previous GD who underwent early postpartum screening for residual dysglycemia were older and had more frequent ambulatory endocrinology visits during pregnancy.

References

1) Li Z, Cheng Y, Wang D, Chen H, Chen H, Ming WK, Wang Z. Incidence Rate of Type 2 Diabetes Mellitus after Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of 170,139 Women. J Diabetes Res. 2020; 2020:3076463.
2) Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020; 369:m1361
3) Ikoh Rph CL, Tang Tinong R. The Incidence and Management of Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus. Cureus. 2023; 15(8):e44468.
4) Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002; 25(10):1862-8.
5) Nuha E, Grazia A, Vanita A, Raveendhara B, Florence B, Dennis B, et al.; on behalf of the American Diabetes Association, 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023. Diabetes Care 2023; 46 (Supplement_1): S254–S266.
6) Nuha E, Grazia A, Vanita A, Raveendhara B, Florence B, Dennis B, et al., American Diabetes Association; 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care 2023; 46 (Supplement_1): S19–S40.
7) Blatt AJ, Nakamoto JM, Kaufman HW. Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol. 2011; 117(1):61-68.
8) Goueslard K, Cottenet J, Mariet AS, Sagot P, Petit JM, Quantin C. Early screening for type 2 diabetes following gestational diabetes mellitus in France: hardly any impact of the 2010 guidelines. Acta Diabetol. 2017; 54(7):645-651.
9) Beischer NA, Wein P, Sheedy MT. A follow-up program for women with previous gestational diabetes mellitus. Med J Aust. 1997; 166(7):353-7.
10) Ferrara A, Peng T, Kim C. Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care. 2009; 32(2):269-74.
11) Hunt KJ, Conway DL. Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol. 2008; 198(4):404.e1-6.
12) Kim C, Tabaei BP, Burke R, McEwen LN, Lash RW, Johnson SL, et al. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health. 2006; 96(9):1643-8.
13) Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020; 135(6):e237-e260.
14) American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstet Gynecol. 2018; 132(6):e228-e248.
15) Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care. 2010; 33(8):1798-804.
16) Kwong S, Mitchell RS, Senior PA, Chik CL. Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care. 2009; 32(12):2242-4.
17) Chaudhry HJ, McDermott B. Recognizing and improving patient nonadherence to statin therapy. Curr Atheroscler Rep. 2008; 10(1):19-24.